Arkolith/Insider Trading/FDMT/Form 4

Bizily Scott

Chief Legal Officer4D Molecular Therapeutics, Inc. (FDMT) · full profile →Form 4 · filed Jul 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$92K
Net Open-Market Flow
-$92K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 30, 2026Option exercise(M)814$4.14$3K9K
Jun 30, 2026Option exercise(M)6K$6.49$37K15K
Jun 30, 2026Sell(S)7K$14.00$92K9K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 30, 2026Option exercise(M)814—$063K
Jun 30, 2026Option exercise(M)6K—$04K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001920738-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML